Free Trial

GlycoMimetics (GLYC) Insider Trading & Ownership

GlycoMimetics logo
$0.23 +0.03 (+13.82%)
(As of 12/20/2024 05:31 PM ET)

GlycoMimetics (NASDAQ:GLYC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.70%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$47,500.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$205,659.45
Get GLYC Insider Trade Alerts

Want to know when executives and insiders are buying or selling GlycoMimetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GLYC Insider Buying and Selling by Quarter

GlycoMimetics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/7/2024Public Equities L.P. InvusMajor ShareholderSell61,488$0.18$11,067.84  
8/5/2024Public Equities L.P. InvusMajor ShareholderSell164,523$0.19$31,259.37  
8/1/2024Public Equities L.P. InvusMajor ShareholderSell63,564$0.22$13,984.08  
7/29/2024Public Equities L.P. InvusMajor ShareholderSell363,949$0.24$87,347.76  
7/26/2024Public Equities L.P. InvusMajor ShareholderSell258,335$0.24$62,000.40  
6/20/2024Edwin RockInsiderBuy190,000$0.25$47,500.00  
(Data available from 1/1/2013 forward)

GLYC Insider Trading Activity - Frequently Asked Questions

The list of insiders at GlycoMimetics includes Brian M Hahn, Bruce S Johnson, Daniel M Junius, Edwin Rock, John L Magnani, Public Equities L.P. Invus, and Scott D Sandell. Learn more on insiders at GLYC.

8.70% of GlycoMimetics stock is owned by insiders. Learn more on GLYC's insider holdings.

The following insiders have purchased GLYC shares in the last 24 months: Bruce S Johnson ($21,195.00), Daniel M Junius ($46,800.00), Edwin Rock ($343,300.00), and Public Equities L.P. Invus ($2,981,601.24).

Insiders have purchased a total of 1,839,951 GLYC shares in the last 24 months for a total of $3,392,896.24 bought.

The following insiders have sold GLYC shares in the last 24 months: Brian M Hahn ($7,215.00), Public Equities L.P. Invus ($205,659.45), and Scott D Sandell ($2,845,225.14).

Insiders have sold a total of 1,813,751 GlycoMimetics shares in the last 24 months for a total of $3,058,099.59 sold.

GlycoMimetics Key Executives

  • Mr. Harout Semerjian (Age 54)
    CEO, President & Director
    Compensation: $1.13M
  • Ms. Rachel K. King (Age 65)
    Co-Founder & Director
    Compensation: $40k
  • Mr. Brian M. Hahn (Age 50)
    Senior VP & CFO
    Compensation: $822.12k
  • Dr. Edwin Rock M.D. (Age 63)
    Ph.D., Senior VP & Chief Medical Officer
    Compensation: $677.4k
  • Ms. Stephanie R. Irish CPA (Age 53)
    Vice President of Accounting
  • Mr. Christian B. Dinneen-Long
    General Counsel & Company Secretary
  • Mr. Bruce Johnson (Age 56)
    Senior VP & Chief Commercial Officer
  • Mr. Chinmaya Rath (Age 47)
    Senior VP & Chief Business Officer
  • Mr. Shantha Tyavanagimatt Ph.D.
    Senior Vice President of Technical Operations


This page (NASDAQ:GLYC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners